WilliamPFayMD
Cardiology • Columbia, MOAdult Congenital Heart Disease, Interventional Cardiology
Professor, Internal Medicine, University of Missouri, Columbia School of Medicine
Dr. Fay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
One Hospital Dr
Columbia, MO 65212Phone+1 573-882-2296Fax+1 573-884-7743- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 1986 - 1990- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1985 - 1986
University of Michigan Health SystemResidency, Internal Medicine, 1982 - 1985
University of Illinois College of MedicineClass of 1982
Certifications & Licensure
MO State Medical License 2004 - 2025
MI State Medical License 1990 - 2015
MN State Medical License 1985 - 1990
IA State Medical License 1986 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- In vitro biological responses of plasma nanocoatings for coronary stent applications.ThiThuHa Phan, John E Jones, Meng Chen, T L Strawn, Hekmat B Khoukaz, Yan Ji, Arun Kumar, Douglas K Bowles, William P Fay, Qingsong Yu> ;Journal of Biomedical Materials Research. Part A. 2023 Nov 1
- Do Fish Oil Supplements Reduce A-Fib?Hekmat B Khoukaz, Manisha Vadali, William P Fay> ;Missouri Medicine. 2023 Jan 2
- 2 citationsA Biocompatibility Study of Plasma Nanocoatings onto Cobalt Chromium L605 Alloy for Cardiovascular Stent Applications.Thithuha Phan, John E Jones, Meng Chen, Doug K Bowles, William P Fay, Qingsong Yu> ;Materials. 2022 Aug 29
- Join now to see all
Other
- Thrombotic and hemorrhagic disorders due to abnormal fibrinolysisFay WP
http://www.uptodate.com/contents/thrombotic-and-hemorrhagic-disorders-due-to-abnormal-fibrinolysis
UpToDate, Wolters Kluwer Health - 2013-03-20
Press Mentions
NextGen Will Raise University's Research PowerJanuary 1st, 2020
Through MU Health Partnership, Moberly Regional Medical Center to Offer Cardiac CareAugust 3rd, 2016
Grant Support
- Roles Of Plasminogen Activator Inhibitor-1 And Vitronectin In Failure Of CoronaryNational Heart, Lung, And Blood Institute2010–2011
- Regulation Of Fibrinolysis At Sites Of Arterial InjuryNational Heart, Lung, And Blood Institute1997–2007
- Regulation Of Platelet-Dependent ThrombosisNational Heart, Lung, And Blood Institute2004
- Regulation Of Platelet-Dependent ThrombosisNational Heart, Lung, And Blood Institute2000–2003
- Structure/Function In Plasminogen Activator Inhibitor-1National Heart, Lung, And Blood Institute1992–1996
Professional Memberships
- Member
Hospital Affiliations
Harry S. Truman Memorial Veterans' HospitalColumbia, Missouri- Pinnacle Regional HospitalBoonville, Missouri
University HospitalColumbia, Missouri- Samaritan HospitalMacon, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
